Experiments for taxon Lyngbya majuscula (OSCILLATORIACEAE)

420 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
242310	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
1303987	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTILEISHMANIASIS ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE E
1280946	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	AURILIDE C
654159	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
260443	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
185525	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
253456	PHARMACOLOGY OF COMPOUND - IN VITRO	TOPOISOMERASE I INHIBITION	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
269643	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN B
185532	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
635536	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
271629	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE B
1287318	PHARMACOLOGY OF EXTRACT - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)
159524	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN BINDING INHIBITION	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
185536	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
1285067	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE B
184030	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
184041	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
185531	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
70829	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	OSCILLATOXIN B
184036	COMPOUND ISOLATED HAS UNUSUAL NAMEISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLIATOXIN
260437	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYA INDANE
263404	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,NOR:
1280941	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	AURILIDE B
430316	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
89238	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D
226476	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
179217	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYA ALPHA-BUTYROLACTONE
229133	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXIC EFFECT(UNSPEC)	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
185529	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
89245	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7(S)-METHOXY: (-):
117945	PHARMACOLOGY OF COMPOUND - IN VIVO	IRRITANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYATOXIN C
85511	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL ATTACHMENT ENHANCEMENT EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	BUTANOIC ACID-GAMMA-LACTONE,3-4-DIHYDROXY: (S): (-):
259048	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE B
1287314	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
211722	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE J
117951	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATIXIN,DEBROMO:
89241	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D ACETATE
286538	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN
129582	PHARMACOLOGY OF COMPOUND - IN VITRO	IMMUNOSUPPRESSANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN B
840114	PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE	CARCINOGENIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN
159528	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
189369	PHARMACOLOGY OF EXTRACT - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)
263400	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,PSEUDO:
194445	PHARMACOLOGY OF EXTRACT - IN VITRO	FEEDING DETERRENT(FISH)	Lyngbya majuscula (OSCILLATORIACEAE)	YPAOAMIDE
988486	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE A
430309	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
97918	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C,57-NOR:
1280945	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)
226481	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE
259049	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE B
178681	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE I
430312	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
194446	PHARMACOLOGY OF EXTRACT - IN VITRO	FEEDING DETERRENT(FISH)	Lyngbya majuscula (OSCILLATORIACEAE)
1308186	PHARMACOLOGY OF COMPOUND - IN VITRO	INSECTICIDE ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE BGRENADAMIDE A
259348	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
211727	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE L
654162	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN BINDING EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
117943	PHARMACOLOGY OF COMPOUND - IN VIVO	IRRITANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYATOXIN B
252859	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
823955	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C#
1298591	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C,DEMETHOXY:
242313	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
259044	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE A
184033	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
70830	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	OSCILLATOXIN B-1
117949	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE A
242308	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
1287320	PHARMACOLOGY OF EXTRACT - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
259403	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE Q
211726	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE K
179216	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYACARBONATE
1304891	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HANTUPEPTIN A
229132	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
843547	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE C
189370	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
297848	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE D
985800	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE C
992819	WRITE LETTER FOR 2 COMPOUNDSUV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE E
889895	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
206138	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	QUINOLINE,6-HYDROXY-4-8-DIMETHYL:
430304	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
226079	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TUBULIN POLYMERIZATION INHIBITION	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN D
1304890	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HANTUPEPTIN A
1279204	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXIC EFFECT(GENERAL)	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
259043	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE A
246788	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2
229125	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
269645	PHARMACOLOGY OF COMPOUND - IN VITRO	SODIUM CHANNEL AGONIST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN A
292526	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE U
259050	ISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7(S)-METHOXY:
259351	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYAPEPTIN A
840117	PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)TOXICITY MARKER CODE	CARCINOGENIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
1308181	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE B
1279086	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTAHAPEPTIN A
1275603	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
178685	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7(S)-METHOXY:
185535	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
983787	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE A
889899	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
219404	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	KALKIPYRONE
263399	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,PSEUDO:
271625	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE A
1303988	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTILEISHMANIASIS ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE A
1285063	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGOMABIN
259405	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE R
159523	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
996891	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGIC ACID
635775	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
229128	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
430301	PHARMACOLOGY OF EXTRACT - IN VIVO	ANALGESIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
297844	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE B
185524	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
253455	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOSKELETON DISORGANIZATION ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
184031	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
70859	GEL PERMEATION CHROMATOGRAPHY USED		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C
1301635	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	NHATRANGIN A
843549	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE C,DEOXY:
253450	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
1287319	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
271628	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE B
184043	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
184042	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
184029	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
259040	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE A
159522	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
996892	YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGIC ACID
430317	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
297850	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE F
89244	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7(S)-METHOXY: (-):
252855	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	OSCILLOTOXIN
1303986	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE ADRAGONAMIDE B
242311	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
430310	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1285064	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE A
260441	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
840115	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
430293	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	SPERMICIDAL EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)
242314	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
178096	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
265968	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE A,ISO:
97919	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C,57-NOR:
1218912	PHARMACOLOGY OF EXTRACT - IN VITRO	PHORBOL ESTER RECEPTOR BINDING	Lyngbya majuscula (OSCILLATORIACEAE)
217459	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN A
1287315	PHARMACOLOGY OF EXTRACT - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)
1218914	PHARMACOLOGY OF COMPOUND - IN VITRO	PHORBOL ESTER RECEPTOR BINDING	Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
246786	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2
260447	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
253449	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
189368	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
260444	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
226075	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN D
840116	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS	IRRITANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
1279090	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREAFFINITY CHROMATOGRAPHY USEDINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTANAPEPTIN C
889891	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
807527	PHARMACOLOGY OF COMPOUND - IN VITRO	NEUROTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
1308184	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN
297843	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE A
31466	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ANTIIMPLANTATION EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)
263397	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE
263403	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,PSEUDO:
430308	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIAMEBIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
229131	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
265970	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE B,ISO:
89240	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D
1285060	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN A
983788	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE B
129583	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN B
185528	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
1301637	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,ANHYDRO:
246787	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2
823954	QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C#
178680	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
184032	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
85510	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	BUTANOIC ACID-GAMMA-LACTONE,3-4-DIHYDROXY: (S): (-):
242307	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
430302	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICONVULSANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1279208	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIFUNGAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
297849	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE E
185539	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
185540	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
1279203	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
614252	PMR SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREFIELD DESORPTION MASS SPECTRUM OFTOXICITY MARKER CODEYIELD IS LESS THAN 50 MGMPHARMACOLOGY OF EXTRACT - IN HUMANS	IRRITANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE A
1308180	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE A
259350	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYAPEPTIN A
70833	ISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:APLYSIATOXIN,ANHYDRO: DEBROMO:
260440	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
1280944	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	AURILIDE B
226480	PHARMACOLOGY OF COMPOUND - IN VITRO	CANNABINOID RECEPTOR BINDING	Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE
98011	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE D,DEOXY:
983792	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE G
889894	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
430297	PHARMACOLOGY OF EXTRACT - IN VIVO	AUTONOMIC EFFECTS(UNSPECIFIED)	Lyngbya majuscula (OSCILLATORIACEAE)
430305	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
226477	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	GRENADADIENE
226076	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
252858	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN
1285058	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN A
179218	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	INDOLE-3-CARBOXALDEHYDE,N-7-DIMETHYL:
159520	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
117948	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE B
229129	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
1272163	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
269644	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN A
1275602	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
271624	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE A
246791	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2,NOR:
1308187	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ITRALAMIDE BHECTOCHLORIN,DEACETYL
219405	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	KALKIPYRONE
889898	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
1027727	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE B
189374	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7-METHOXY: (-):
259047	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE B
292527	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE V
654161	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN BINDING EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
211723	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE K
189371	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
265967	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE A,ISO:
178684	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
178095	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
252854	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	DOLASTATIN 3
159525	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMITOTIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
430313	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1287316	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
211720	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE J
263396	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN B
1285065	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE A
260446	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
987683	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	HEXADECA-TRANS-4-TRANS-8-DIENOIC ACID,9-METHYL: 7-METHOXY:
129579	PHARMACOLOGY OF COMPOUND - IN VITRO	IMMUNOSUPPRESSANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN A
840112	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN
259041	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE A
70858	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDORD SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C
1304888	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
889896	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
265969	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE B,ISO:
1218911	VOUCHER SPECIMEN REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)
260439	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYA INDANE
983789	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE D
259349	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYAPEPTIN A
253454	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
430294	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOGLYCEMIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1027726	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE A
843548	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE C ACETATE
1298770	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE C,DEMETHOXY:
117947	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE A
654160	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN BINDING EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
1303985	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE E
229126	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
263398	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENAMIDE
184038	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLIATOXIN
1279210	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CAYLOBOLIDE A
259352	ISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
271627	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE B
185538	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
1285061	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	DRAGOMABIN
159521	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
807526	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
117942	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYATOXIN B
286540	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN
1027728	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE C
178097	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
1279091	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTANAPEPTIN D
1308183	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	ITRALAMIDE B
889892	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
1279209	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CAYLOBOLIDE A
1280943	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	AURILIDE B
253448	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
185527	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
1301638	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,ANHYDRO: DEBROMO:
1301636	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	NHATRANGIN B
219406	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	KALKIPYRONE
70832	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	OSCILLATOXIN D,30-METHYL:
269641	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN B
271623	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE A
89243	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7(S)-METHOXY: (-):
807525	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCORRECTION OF STRUCTUREISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
159526	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
259353	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
129580	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN A
226077	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN D
1279089	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTANAPEPTIN B
1285057	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
184039	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLIATOXIN
996893	YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGIC ACID
229130	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
292528	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE W
614253	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDABSOLUTE CONFIGURATION DETERMINEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS 50-100 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE B
206137	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	QUINOLINE,4-8-DIMETHYL-6-O-(2'-4'-DI-O-METHYL-BETA-D-XYLOPYRANOSYL)-HYDROXY:
983790	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE E
226478	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	GRENADAMIDE
286541	PHARMACOLOGY OF COMPOUND - IN VITRO	ACTIN POLYMERIZATION STIMULANT	Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN
98010	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE D,DEOXY:
178683	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE I
430314	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
229123	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1
1308188	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORINGRENADAMIDE BITRALAMIDE AGRENADAMIDE A
244639	ISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE G
179219	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYA MONOTERPENE 4
252857	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	KORORAMIDE
184035	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
981707	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	TELEOCIDIN A
98008	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE D
211724	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE L
185530	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
244638	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTED		Lyngbya majuscula (OSCILLATORIACEAE)	DODEC-TRANS-4-ENOIC ACID,7-METHOXY: (-):
260442	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
189372	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
983791	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	PUKELEIMIDE F
1279202	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
889897	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
430306	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
246790	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2,NOR:
185533	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
242304	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDORD SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
263402	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,PSEUDO:
253451	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
520505	UV SPECTRUM GIVEN FORABSOLUTE CONFIGURATION DETERMINEDISOLATION AND IDENTIFICATION OFSTEREOCHEMISTRY DETERMINED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
297842	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE A
194444	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	YPAOAMIDE
430295	PHARMACOLOGY OF EXTRACT - IN VIVO	RESPIRATORY DEPRESSANT	Lyngbya majuscula (OSCILLATORIACEAE)
430298	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOLYTIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
185541	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN C
242309	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
260445	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
992818	WRITE LETTER FOR 2 COMPOUNDSPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS 50-100 MGMINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D
217460	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN B
1285068	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE B
259046	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE B
259346	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
1304889	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	HANTUPEPTIN A
1027725	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	LINOLENIC ACID ETHYL ESTER
70831	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	OSCILLATOXIN B-2
430296	PHARMACOLOGY OF EXTRACT - IN VIVO	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	Lyngbya majuscula (OSCILLATORIACEAE)
1308182	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	ITRALAMIDE A
1279092	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	DOLASTATIN 16
297841	VOUCHER SPECIMEN REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)
889893	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGOLIDE
229127	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
297846	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE C
840113	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS	IRRITANT ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN
129578	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN A
1285066	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGONAMIDE A
1280947	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	AURILIDE C
259404	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE R
246789	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 2,NOR:
1275605	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
117946	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	TELEOCIDIN A
1308185	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN,DEACETYL
184037	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLIATOXIN
260438	PHARMACOLOGY OF COMPOUND - IN VITRO	GENE EXPRESSION INHIBITION	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYA INDANE
1287317	PHARMACOLOGY OF COMPOUND - IN VITRO	MOLLUSCICIDAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
185537	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
263395	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN A
1279087	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DOLASTATIN 16ANTANAPEPTIN CANTANAPEPTIN BANTAHAPEPTIN AANTANAPEPTIN D
229134	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
211721	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE J
85512	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	TUMOR PROMOTING EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	BUTANOIC ACID-GAMMA-LACTONE,3-4-DIHYDROXY: (S): (-):
1280942	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
430315	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1218913	HPLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	APLYSIATOXIN,DEBROMO:
89242	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D ACETATE
89239	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE D
286539	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	HECTOCHLORIN
129581	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	MICROCOLIN B
430303	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
269642	PHARMACOLOGY OF COMPOUND - IN VITRO	SODIUM CHANNEL AGONIST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN B
211725	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE K
843550	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE C,DIDEOXY:
811362	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTEDYIELD IS LESS THAN 50 MGM		Lyngbya majuscula (OSCILLATORIACEAE)	BUTYROLACTONE,GAMMA: ALPHA-(S)-BUTYRAMIDO: (+):
271626	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE A
698968	VOUCHER SPECIMEN REPORTED FORBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE,DECHLORO:BARBAMIDE
242306	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
211728	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE L
259042	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE A
185534	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
654163	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN BINDING EFFECT	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
430307	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
89246	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	SULFUR
117944	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYATOXIN C
178682	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE I
1027724	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-4-ENOIC ACID,TRANS-7(S)-METHOXY: (-):
430318	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
159527	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMITOTIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A
430311	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
226475	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORCOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	GRENADADIENE,DEBROMO:
226078	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN D
184040	ISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MALYNGAMIDE H
229124	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROFILAMENT DISRUPTION	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:LYNGBYASTATIN 1
252856	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	DOLASTATIN 3,HOMO:
242312	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIALGAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	TANIKOLIDE
242305	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1279205	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
271630	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	PITIPEPTOLIDE B
297847	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE C
269646	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN A
1285059	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CARMABIN A
382377	CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
259045	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	HERMITAMIDE B
185523	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN B
98009	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE D
229135	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYASTATIN 1,15-EPI:
297845	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GUINEAMIDE B
189373	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	TETRADEC-TRANS-4-ENOIC ACID,7-METHOXY: (-):
253452	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXIC EFFECT(GENERAL)	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
430299	PHARMACOLOGY OF EXTRACT - IN VITRO	SPASMOGENIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1285062	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMALARIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DRAGOMABIN
226479	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	GRENADADIENE
1279088	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DOLASTATIN 16ANTANAPEPTIN CANTANAPEPTIN BANTAHAPEPTIN AANTANAPEPTIN D
185526	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN BCURACIN C
253453	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
263401	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	DYSIDENIN,PSEUDO:
430300	PHARMACOLOGY OF EXTRACT - IN VIVO	CNS EFFECTS(GENERAL)	Lyngbya majuscula (OSCILLATORIACEAE)
184034	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Lyngbya majuscula (OSCILLATORIACEAE)	BARBAMIDE
259347	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN B
1275604	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	APRATOXIN A
179215	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)
1287313	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPOUND ISOLATED HAS UNUSUAL NAME		Lyngbya majuscula (OSCILLATORIACEAE)	ANTILLATOXIN
117950	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	MAJUSCULAMIDE B
259354	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lyngbya majuscula (OSCILLATORIACEAE)	LYNGBYABELLIN A
185542	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lyngbya majuscula (OSCILLATORIACEAE)	CURACIN A

Experiments for taxon Lyngbya majuscula (OSCILLATORIACEAE)

Experiments (420 results)

Filters

Worktypes (40)

Pharmacology (50)

Compounds (136)

Organisms (80)